Uncategorized

Prostate cancer: Poor prognosis in men with diabetes

Anne Li                                                                                     Feburary 2nd, 2018   Men with type…...

Read more

Stealth virus for cancer therapy

Anne Li                                                                                     Feburary 2nd, 2018   Scientists have redesigned…...

Read more

Breast cancer drug approved for NHS in England

Anne Li                                                                                     Feburary 2nd, 2018   A drug for…...

Read more

NHS radiotherapy changes could see more patients having modern treatment

Anne Li                                                                                     Feburary 2nd, 2018   Each of the…...

Read more

Cancer survival improving globally, but UK lagging behind

Anne Li                                                                                     Feburary 2nd, 2018   Cancer survival is…...

Read more

Headlines saying ‘vaping might cause cancer’ are wildly misleading

Anne Li                                                                                     Feburary 2nd, 2018   The recent news…...

Read more

Millennials shun face-to-face conversations for online chats

Anne Li                                                                                     Feburary 2nd, 2018   Millennials are shunning…...

Read more

News digest – Tessa Jowell, cervical screening ‘embarrassment’, modified flu virus and… monkey clones?

Anne Li                                                                                     Feburary 2nd, 2018   This week, Cancer…...

Read more

Apalutamide delays spread of certain prostate cancers in trial

Anne Li                    2/9/18   An experimental hormone therapy delays the spread of prostate cancer that has stopped responding to standard treatment, according to new clinical trial results. The drug, called apalutamide, reduced the risk of either the cancer spreading or death…...

Read more

Apalutamide delays progression of nonmetastatic, castration-resistant prostate cancer

Anne Li                        2/9/18   Treatment with an investigational androgen receptor inhibitor significantly delayed the development of metastasis in patients with prostate cancer that had become resistant to standard androgen-deprivation therapy. The results of a multi-institutional, phase 3 clinical trial…...

Read more